Article Details

SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments ...

Retrieved on: 2021-01-07 21:56:15

Tags for this article:

Click the tags to see associated articles and topics

SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments .... View article details on hiswai:

Excerpt

The financing, which was led by Vensana Capital alongside existing investor New Enterprise Associates (“NEA”), will enable the company to further ...

Article found on: www.prweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up